Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Amit

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenolsSilvia A Mandel, Orly Weinreb, Tamar Amit, et al.
Journal of Alzheimer'S Disease : JAD|March 4, 2011
Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseasesSilvia A Mandel, Tamar Amit, Orly Weinreb, et al.
International Review of Neurobiology|October 6, 2011
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitorOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
British Journal of Pharmacology|September 3, 2015
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's diseaseOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processingMerav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 28, 2009
Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrainOrly Weinreb, Tamar Amit, Yotam Sagi, et al.
Molecular Nutrition & Food Research|February 14, 2006
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disordersSilvia Mandel, Tamar Amit, Lydia Reznichenko, et al.
Antioxidants & Redox Signaling|January 26, 2010
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunitiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Neuropharmacology|June 19, 2015
Beneficial behavioral, neurochemical and molecular effects of 1-(R)-aminoindan in aged miceFelix Badinter, Tamar Amit, Orit Bar-Am, et al.
Neurobiology of Aging|July 5, 2015
Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged miceOrly Weinreb, Felix Badinter, Tamar Amit, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenolsSilvia A Mandel, Orly Weinreb, Tamar Amit, et al.
Journal of Alzheimer'S Disease : JAD|March 4, 2011
Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseasesSilvia A Mandel, Tamar Amit, Orly Weinreb, et al.
International Review of Neurobiology|October 6, 2011
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitorOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
British Journal of Pharmacology|September 3, 2015
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's diseaseOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processingMerav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 28, 2009
Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrainOrly Weinreb, Tamar Amit, Yotam Sagi, et al.
Molecular Nutrition & Food Research|February 14, 2006
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disordersSilvia Mandel, Tamar Amit, Lydia Reznichenko, et al.
Antioxidants & Redox Signaling|January 26, 2010
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunitiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Neuropharmacology|June 19, 2015
Beneficial behavioral, neurochemical and molecular effects of 1-(R)-aminoindan in aged miceFelix Badinter, Tamar Amit, Orit Bar-Am, et al.
Neurobiology of Aging|July 5, 2015
Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged miceOrly Weinreb, Felix Badinter, Tamar Amit, et al.
Pageof 9